Conscience, Genes, Boundaries

Three perspectives from chemistry, medicine, and ethics shed light on what nanomaterials and gene transfer technologies are actually capable of today, relating scientific reality to societal expectations — including comparisons with familiar portrayals in film and media. At the center of the discussion is the question of how the European and German regulatory framework balances innovation, safety, and public acceptance while clearly distinguishing between different forms of biomedical intervention. The event also explores, in an accessible way, the opportunities offered by modern nucleic acid therapies and how cultural influences as well as global developments shape our approach to biomedical technologies.